|
[1]
|
Asrani, S.K., Devarbhavi, H., Eaton, J. and Kamath, P.S. (2019) Burden of Liver Diseases in the World. Journal of Hepatology, 70, 151-171. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Alqahtani, S.A., Chan, W. and Yu, M. (2023) Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Clinics in Liver Disease, 27, 211-223. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Pereira, F., Azevedo, R., Linhares, M., Pinto, J., Leitão, C., Caldeira, A., et al. (2020) Hepatic Osteodystrophy in Cirrhosis Due to Alcohol-Related Liver Disease. Revista Española de Enfermedades Digestivas, 113, 563-569. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Colantoni, A., Bucci, T., Cocomello, N., Angelico, F., Ettorre, E., Pastori, D., et al. (2024) Lipid-Based Insulin-Resistance Markers Predict Cardiovascular Events in Metabolic Dysfunction Associated Steatotic Liver Disease. Cardiovascular Diabetology, 23, Article No. 175. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Mastrototaro, L. and Roden, M. (2021) Insulin Resistance and Insulin Sensitizing Agents. Metabolism, 125, Article 154892. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Khalid, M., Alkaabi, J., Khan, M.A.B. and Adem, A. (2021) Insulin Signal Transduction Perturbations in Insulin Resistance. International Journal of Molecular Sciences, 22, Article 8590. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ding, C., Ng Fat, L., Britton, A., Im, P.K., Lin, K., Topiwala, A., et al. (2023) Binge-Pattern Alcohol Consumption and Genetic Risk as Determinants of Alcohol-Related Liver Disease. Nature Communications, 14, Article No. 8041. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
DeFronzo, R.A., Tobin, J.D. and Andres, R. (1979) Glucose Clamp Technique: A Method for Quantifying Insulin Secretion and Resistance. American Journal of Physiology-Endocrinology and Metabolism, 237, E214-E223. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Saei Ghare Naz, M., Mousavi, M., Firouzi, F., Momenan, A.A., Azizi, F. and Ramezani Tehrani, F. (2024) Association between Insulin Resistance Indices and Liver Function Parameters among Women with Polycystic Ovary Syndrome. Endocrinology, Diabetes & Metabolism, 7, e490. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Fan, Z., Yang, C., Zhao, X. and Zhang, J. (2025) Association of Cardiometabolic Markers with Hepatic Steatosis and Liver Fibrosis in Population without Obesity and Diabetes. Scientific Reports, 15, Article No. 15695. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kuo, T., Lu, Y., Yang, C., Wang, B., Chen, L. and Su, C. (2024) Association of Insulin Resistance Indicators with Hepatic Steatosis and Fibrosis in Patients with Metabolic Syndrome. BMC Gastroenterology, 24, Article No. 26. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Nádasdi, Á., Gál, V., Masszi, T., Somogyi, A. and Firneisz, G. (2023) PNPLA3 Rs738409 Risk Genotype Decouples Tyg Index from HOMA2-IR and Intrahepatic Lipid Content. Cardiovascular Diabetology, 22, Article No. 64. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhao, X., An, X., Yang, C., Sun, W., Ji, H. and Lian, F. (2023) The Crucial Role and Mechanism of Insulin Resistance in Metabolic Disease. Frontiers in Endocrinology, 14, Article ID: 1149239. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zeng, P., Cai, X., Yu, X. and Gong, L. (2023) Markers of Insulin Resistance Associated with Non-Alcoholic Fatty Liver Disease in Non-Diabetic Population. Scientific Reports, 13, Article No. 20470. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Yu, X., Chao, J., Wang, X., Dun, S., Song, H., Guo, Y., et al. (2025) Sarcopenic Obesity and the Risk of Atrial Fibrillation in Non-Diabetic Older Adults: A Prospective Cohort Study. Clinical Nutrition, 47, 282-290. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Vergani, M., Borella, N.D., Rizzo, M., Conti, M., Perra, S., Bianconi, E., et al. (2025) Metabolic Dysfunction‐Associated Steatotic Liver Disease, Insulin Sensitivity and Continuous Glucose Monitoring Metrics in Patients with Type 1 Diabetes: A Multi‐Centre Cross‐Sectional Study. Diabetes, Obesity and Metabolism, 27, 3201-3211. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Peng, W., Li, Z. and Fu, N. (2025) Association between eGDR and MASLD and Liver Fibrosis: A Cross-Sectional Study Based on NHANES 2017-2023. Frontiers in Medicine, 12, Article ID: 1579879. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Liu, Y., Lin, H., Jiang, L., Shang, Q., Yin, L., Lin, J.D., et al. (2020) Hepatic Slug Epigenetically Promotes Liver Lipogenesis, Fatty Liver Disease, and Type 2 Diabetes. Journal of Clinical Investigation, 130, 2992-3004. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Liu, D., Lv, X., Li, W., Dai, H., Tan, Y., Yang, D., et al. (2025) Association between Estimated Glucose Disposal Rate and Metabolic Dysfunction-Associated Steatotic Liver Disease and Dyslipidemia in US Adults: A Cross-Sectional Study. Frontiers in Nutrition, 12, Article ID: 1621074. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Liu, R., Liu, R., Liu, M., Tian, Y., Liu, J., Wang, Y., et al. (2025) The Inflammatory Index and Cytokines Are Associated with Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus. Frontiers in Medicine, 12, Article ID: 1659998. [Google Scholar] [CrossRef]
|
|
[21]
|
Cao, T., Zhu, Q., Tong, C., Halengbieke, A., Ni, X., Tang, J., et al. (2024) Establishment of a Machine Learning Predictive Model for Non-Alcoholic Fatty Liver Disease: A Longitudinal Cohort Study. Nutrition, Metabolism and Cardiovascular Diseases, 34, 1456-1466. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Zhao, Y., Hu, D., Cheng, J., Cao, H., Wang, X., He, J., et al. (2025) Personalized MASLD and Liver Fibrosis Risk Assessment for Adults: Glycemic Status Determines Optimal Choice of Non-Invasive Indices. Diabetology & Metabolic Syndrome, 17, Article No. 461. [Google Scholar] [CrossRef]
|
|
[23]
|
Han, A.L., Lee, H.K. and Shin, S.R. (2024) Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease. Metabolic Syndrome and Related Disorders, 22, 402-409. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Yang, B., Gong, M., Zhu, X., Luo, Y., Li, R., Meng, H., et al. (2025) Correlation between Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Insulin Resistance Indicators: A Cross-Sectional Study from NHANES 2017-2020. Frontiers in Endocrinology, 16, Article ID: 1514093. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Zhang, Y., Wu, J., Li, T., Qu, Y. and Wang, Y. (2025) Association of Triglyceride-Glucose Related Indices with Mortality among Individuals with MASLD Combined with Prediabetes or Diabetes. Cardiovascular Diabetology, 24, Article No. 52. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Grzelka-Woźniak, A., Uruska, A., Szymańska-Garbacz, E., Araszkiewicz, A., Jabłkowski, M., Czupryniak, L., et al. (2023) Indirect Insulin Resistance Markers in Relation to Nonalcoholic Fatty Liver Disease among Patients with Type 1 Diabetes Mellitus. Authors’ Reply. Polish Archives of Internal Medicine, 133, Article No. 16406. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Semmler, G., Balcar, L., Wernly, S., Völkerer, A., Semmler, L., Hauptmann, L., et al. (2023) Insulin Resistance and Central Obesity Determine Hepatic Steatosis and Explain Cardiovascular Risk in Steatotic Liver Disease. Frontiers in Endocrinology, 14, Article ID: 1244405. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Megalaa, M.H., Zeid, A., Zietoun, M., Salem, D.M. and Elrahmany, S.M. (2025) Triglyceride Glucose Index and Related Parameters Are Effective Biomarkers to Identify Metabolic Dysfunction-Associated Steatotic Liver Disease among Egyptian Adults with Type 2 Diabetes. Metabolic Syndrome and Related Disorders, 23, 394-404. [Google Scholar] [CrossRef]
|